Table 4 Multivariable multinomial random-effects logistic regression model on the predictors of positive and negative symptom trajectories in controls.

From: Six-year trajectories and associated factors of positive and negative symptoms in schizophrenia patients, siblings, and controls: Genetic Risk and Outcome of Psychosis (GROUP) study

Predictors

Positive symptom trajectories (Ref = Low)

Negative symptom trajectories (Ref = Low)

Moderate

High-decreased

Moderate

High

OR (95% CI)

P-value

OR (95% CI)

P-value

OR (95% CI)

P-value

OR (95% CI)

P-value

Schizophrenia polygenic risk scores

 PRSPT=0.05

1.03 (0.90; 1.19)

0.64

0.96 (0.8; 1.16)

0.69

1.01 (0.90; 1.13)

0.87

1.00 (0.88; 1.14)

0.97

Demographic and clinical characteristics

 Age

0.96 (0.89; 1.02)

0.20

0.91 (0.83; 1.00)

0.05

    

 Ethnicity, non-Caucasian

2.01 (0.14; 28.05)

0.60

0.84 (0.02; 37.89)

0.93

    

 Premorbid adjustment

2.68 (0.58; 12.34)

0.20

2.50 (0.4; 15.63)

0.33

2.01 (0.49; 8.24)

0.33

5.10 (1.1; 23.57)

0.04

Psychotic-like experiences (distress)

 Positive symptoms

1.42 (0.26; 7.68)

0.68

3.25 (0.37; 28.45)

0.29

2.40 (0.52; 11.07)

0.26

5.39 (0.89; 32.75)

0.07

 Negative symptoms

2.62 (0.36; 19.27)

0.34

2.47 (0.16; 38.45)

0.52

0.62 (0.13; 2.95)

0.55

0.21 (0.03; 1.65)

0.14

 Depressive symptoms

2.75 (0.44; 17.30)

0.28

4.55 (0.44; 47.14)

0.20

4.65 (0.39; 54.66)

0.22

8.48 (0.62; 116.37)

0.11

Quality of life and functioning

 Health-related quality of life

0.19 (0.02; 2.20)

0.18

0.04 (0.00; 0.79)

0.03

0.60 (0.09; 3.85)

0.59

0.10 (0.01; 0.86)

0.04

  1. Significant values are in bold.